Department of Medicine

March 14, 2013

Recruitments bolster personalized medicine initiative

VUMC’s personalized medicine effort is getting a major boost with the recruitment of two physician-scientists from Australia who will increase Vanderbilt’s strength in translational immunology, the translation of basic immunological discoveries into clinically useful tools.

By Nancy Humphrey
March 14, 2013

Heart failure therapy shows promise in early clinical trial

Vanderbilt University Medical Center and Acorda Therapeutics Inc. released findings from a Phase 1 clinical trial of glial growth factor 2 (GGF2) last week at the American College of Cardiology Annual Scientific Session in San Francisco.

By Kathy Whitney
February 28, 2013

Potent genetic risk factor for breast cancer identified

Researchers at Vanderbilt University have found a powerful new genetic risk factor for breast cancer.

By Bill Snyder
February 21, 2013

VU experts help craft AMA paper on safe transitions for patients

“There and Home Again, Safely: 5 Responsibilities of Ambulatory Practices in High Quality Care Transitions,” a new white paper from the American Medical Association (AMA), is the work of a 19-member expert panel that included two Vanderbilt faculty members — Sunil Kripalani, M.D., M.Sc., associate professor of Medicine, and Amanda Salanitro M.D., MS, MSPH, instructor in Medicine, both from the section of Hospital Medicine in the Department of Medicine’s Division of General Internal Medicine and Public Health.

By Paul Govern
February 6, 2013

Linking oxygen, iron and red blood cells

The HIF oxygen-sensing pathway and its responses to low oxygen may be targeted for treatments of anemia and disorders of iron balance.

By Leigh MacMillan
January 31, 2013

Vanderbilt, GE unite to study colon tumor development

Vanderbilt University has partnered with GE Global Research in Niskayuna, N.Y., the technology development arm of the General Electric Company, to better define — at the cellular level — how colon tumors form and develop.

By Bill Snyder
January 31, 2013

Do-it-yourself repair in the kidney

The kidney can mediate its own repair through proliferation of resident immune system cells.
By Leigh MacMillan
January 10, 2013

Three new genetic links to colorectal cancer revealed

Vanderbilt-Ingram Cancer Center investigators have identified three new genetic “hotspots” linked to colorectal cancer.
By VUMC News and Communications
January 10, 2013

Study reviews medication adherence interventions

According to a medical literature review published last month in the Annals of Internal Medicine, approximately 50 percent of medications for chronic disease are not taken as prescribed.
By Paul Govern
December 13, 2012

Hood takes role as associate chief medical officer for VMG

Cardiologist Rob Hood, M.D., assistant professor of Medicine and assistant chief medical officer for the clinics at Vanderbilt Health One Hundred Oaks, has been named associate chief medical officer for Vanderbilt Medical Group.
By Paul Govern
December 7, 2012

Vanderbilt study finds diverse genetic alterations in triple-negative breast cancers

Most triple-negative breast cancer patients who were treated with chemotherapy to shrink the tumor prior to surgery still had multiple genetic mutations in their tumor cells, according to a study by Vanderbilt-Ingram Cancer Center (VICC) investigators.
By VUMC News and Communications
November 29, 2012

Record number elected AAAS fellows

Seventeen members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science (AAAS) this year.
By Bill Snyder
November 15, 2012

Heart Association honors Roden’s research efforts

Dan Roden, M.D., assistant vice chancellor for Personalized Medicine and William Stokes Professor of Experimental Therapeutics, received a 2012 Distinguished Scientist Award at the annual Scientific Sessions of the American Heart Association (AHA) last week in Los Angeles.
By Kathy Whitney
1 … 101 102 103 104 105 … 116